Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.

Clinical trial NCT03697226 · COMPLETED

Trial details

NCT number: NCT03697226
Sponsor: Antiva Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HSIL of Cervix HSIL, High Grade Squamous Intraepithelial Lesions High-Grade Cervical Intraepithelial Neoplasia Human Papilloma Virus HIV Negative Cervical Cancer CIN - Cervical Intraepithelial Neoplasia Cervical Neoplasm Cervical Dysplasia

Start date: 2018-12-21
Primary completion: 2020-05-26
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.